使用牧通人才网APP
轻轻松松找工作
使用牧通人才网APP
轻轻松松找工作
With the goal of accelerating its development in China, Pancosma becomes the majority shareholder of Jangsu Keybio Biology Technology Co. Ltd, a Chinese company producing additives.
为了加快在中国的发展，潘可士玛正式收购了饲料添加剂生产企业江苏晶标生物科技有限公司，并成为其大股东。
Pancosma and Keybio: a durable partnership serving a shared objective for growth
潘可士玛和晶标公司：共同致力于成长的长久合作伙伴
Pancosma announces the acquisition of an 80% majority shareholding in Jangsu Keybio Biology Technology Co Ltd, a Chinese company specialized in additives. The remaining 20% of the capital are retained by Jangsu Hanshang Import & Export Co Ltd which is Pancosma's long-standing partner in China. "Pancosma's strong momentum and numerous investments worldwide, coupled with Keybio's strengths, promise the potential for major product development and quality solutions for the Chinese market" emphasized Haoming Zhang (CEO of JH Import & Export Co Ltd) confirming his commitment to Pancosma.
潘可士玛收购江苏晶标生物科技有限公司80%的股份，江苏晶标生物科技有限公司是一家专门从事饲料添加剂生产的中国公司，其余20%的股份由潘可士玛在中国的长期合作伙伴-江苏汉商进出口有限公司保留。“潘可士玛的强劲势头及在世界各地的众多投资，再加上晶标公司的优势，这对潘可士玛为中国市场提供更多质优价廉的产品与综合性的技术解决方案奠定了基础”江苏汉商进出口有限公司CEO张浩明先生强调。
Strengthening the offer with tailor made solutions dedicated to the Chinese market
加强了中国市场为客户提供量身定制的解决方案
China is the world's largest market in animal nutrition with over 180 million tonnes of feed produced every year. Dr. Goetz Gotterbarm, CEO of Pancosma explained: “This partnership strengthens our position in China. Pancosma will invest in high profile encapsulation technologies on the Zhangjiagang site. Once completed, Pancosma’s portfolio and approach will be fully available to the Chinese market, in particular, our proven science-minded technologies as well as high profile tailor made solutions for Chinese customers”.
中国是世界上畜禽养殖量最大的国家，每年生产的饲料超过1.8亿吨，位居世界前列。潘可士玛首席执行官Goetz Gotterbarm博士解释说，这种合作关系增强了潘可士玛在中国的地位。潘可士玛将在张家港工厂投资高端微胶囊生产技术， 一旦完成，潘可士玛的产品融合技术工艺，特别是我们已经经过验证的科技创新技术以及为中国客户量身定制的解决方案都将会逐步应用到中国市场。
Major synergies and industrial investment for increased competitiveness in China
主要的协同效应和进一步的产业投资，将会提高潘可士玛在中国的竞争力
The merger of the two companies favours the deployment of Pancosma's latest advances in R&D in China (for example the concepts of "non-nutrition", Gut Effect, 17 families of patents, more than 100 peer reviewed articles). It also guarantees high-level international expertise on the ground. The construction of the new production site, coupled with the employment of additional local skills (operators, sales representatives, administrative staff), will enable Pancosma to better meet the substantial needs of the Chinese market.
两家公司的合并有利于将潘可士玛的最新研发成果在中国市场应用(例如“非营养”，肠道效应，17个家族的专利，100多篇同行评审的研发文章)，同时还能保证高水平国际营养专家的服务。新生产基地的建设，加上本地人才(工人，销售代表，行政人员)等的使用，将使潘可士玛能更好地满足中国市场的可持续性需求
About Jangsu Keybio Biology Technology Co Ltd
关于江苏晶标生物科技有限公司
Founded in 2010, Jangsu Keybio Biology Technology Co Ltd is located in the free zone of Zhangjiagang port (located east of Shanghai) on the Yangtze River. The company has a production plant, a laboratory, two warehouses, and enjoys a prime location with over 13,000 m2 of land.
江苏晶标生物科技有限公司成立于2010年，位于长江的张家港港口(上海东部)的自由贸易区。 公司拥有一个生产车间，一个实验室，两个仓库，位于一个黄金地段，并拥有超过13000平方米的厂区。
About Pancosma & Associates
关于潘可士玛集团
Established in 1947, Pancosma & Associates is a pioneer in the development, production, and distribution of a wide range of additives and ingredients for innovative specialities. The company is based in Geneva, Switzerland, and operates in over 75 countries worldwide. For more information: www.pancosma.com
潘可士玛集团成立于1947年，总部位于瑞士日内瓦，业务遍布全球75个国家和地区，是研发，制造和销售各种动物营养品的先驱。更多信息请访问：www.pancosma.com
Contact
联系我们
Rohini Kashimshetty - Press & Communication Manager
Rohini Kashimshetty-潘可士玛新闻传播经理